Redmile Group, LLC - APREA THERAPEUTICS INC ownership

APREA THERAPEUTICS INC's ticker is APRE and the CUSIP is 03836J102. A total of 43 filers reported holding APREA THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.80 and the average weighting 0.0%.

Quarter-by-quarter ownership
Redmile Group, LLC ownership history of APREA THERAPEUTICS INC
ValueSharesWeighting
Q3 2021$3,551,000
+4.7%
694,9180.0%0.06%
+24.0%
Q2 2021$3,391,000
-4.3%
694,9180.0%0.05%0.0%
Q1 2021$3,544,000
-43.2%
694,918
-45.2%
0.05%
-34.2%
Q4 2020$6,242,000
-88.6%
1,268,718
-44.1%
0.08%
-92.4%
Q3 2020$54,585,000
-38.0%
2,268,7180.0%1.00%
-38.3%
Q2 2020$87,981,000
+11.6%
2,268,7180.0%1.62%
-26.5%
Q1 2020$78,861,000
-24.3%
2,268,7180.0%2.21%
-11.2%
Q4 2019$104,111,0002,268,7182.49%
Other shareholders
APREA THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Versant Venture Management, LLC 1,259,662$6,437,0002.66%
COASTAL INVESTMENT MANAGEMENT, L.P. 41,965$214,0000.30%
Redmile Group, LLC 694,918$3,551,0000.06%
Quantamental Technologies LLC 13,752$70,0000.05%
KENNEDY CAPITAL MANAGEMENT LLC 342,486$1,750,0000.04%
PDT Partners, LLC 87,734$448,0000.03%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 75,000$383,0000.01%
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC 49,100$251,0000.01%
NEXT Financial Group, Inc 11,347$58,0000.01%
Sugarloaf Wealth Management, LLC 1,500$8,0000.00%
View complete list of APREA THERAPEUTICS INC shareholders